Fiona du Monceau
Executive VP | UCB
Fiona du Monceau is Executive Vice President and Chief Commercial Officer at UCB, where she leads the worldwide commercialisation of the company’s medicines and global strategy for bringing them to patients.
Her career spans several sides of the biopharmaceutical industry. Before taking on her current role, she led Patient Evidence at UCB, covering areas including clinical development, medical affairs, market access, health technology assessment and real-world evidence. She previously served as COO of VIB spin-off ExeVir Bio and as a Venture Partner at UCB Ventures.
At FTI Leuven, du Monceau joins Paul Stoffels for the discussion on Europe’s competitiveness in life sciences. She brings a perspective that goes beyond discovering a medicine: how do you generate the evidence, navigate access and reimbursement, launch successfully across different markets and ultimately make breakthrough innovation reach patients at scale?
A line-up of human-centric innovators
These extraordinary technology experts know their way around the latest innovations, but they always keep in mind that we're extra ordinary first.
